Michael Gilman, biotech entrepreneur: I am — as a parent and grandparent, rather than a life science executive — considerably ...

Coal India aims to eliminate ECL's losses and rejoin the dividend list by FY'26, with subsidiary Bharat Coking Coal already achieving this. The company also plans to boost production and reduce... Nov ...

With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

The Chicago region’s lab real estate hit 40% vacancy in Q3, according to new CBRE data. In the city proper, that number rises ...

The London Stock Exchange is filled with lucrative dividend stocks waiting to be discovered. Here are two long-term winners ...

Sweden has blocked more than a dozen offshore wind farms in the Baltic Sea over fears they could make the country more ...

In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Krystal Biotech (KRYS – Research Report), with a price target of $208.00. Ritu Baral has given his Buy rating ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Morning! Today, we see even ...

Krishnan, Chairman and CEO of Krystal Biotech. “With key milestones recently achieved in Europe and Japan and the anticipated initiation of the registrational trial to treat corneal abrasions in ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning, major news this ...

which would completely transform the energy landscape,” said Whyte. Although starkly different fields, fusion and biotech share many of the same obstacles to commercialization, including ...